Wednesday, 22 Jan 2020

You are here

Panel Presentation: Psoriatic Arthritis

Drs. Eric Ruderman, Alexis Ogdie, Jessica Walsh, and Jose Scher discuss the giselkumab trials, where IL-23 inhibitors fit in practice, ixekizumab withdrawal, and more that presented at the 2019 ACR/ARP annual meeting in Atlanta.

Add new comment

Want to talk about this video? Comment here to lead the discussion.
MORE VIDEOS

The RheumNow Week in Review – 6 May 2016

06 May 2016

Drs. Suleman Bhana, Paul Sufka and...

23 Oct 2018

Dr. Leslie Bilello: The Emergency...

09 Feb 2018

RheumNow Podcast – Fight or Switching...

18 Oct 2019

RheumNow Live Preview with Dr. Richard...

19 Apr 2019

Pearls for Evaluating PsA Patients: Dr...

20 Nov 2019

Dr. Leonard Calabrese: Shingles and...

09 Nov 2015

QD Clinic - Five Leflunomide Pearls

06 Mar 2019

RheumNow Podcast - The Elusive Hand OA...

13 Dec 2019

The RheumNow Week in Review – FDA...

27 Apr 2018

Dr. Alvin Wells: Imaging

11 Feb 2018

QD Clinic - A Different Kind of Visit

27 Jan 2019